These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9746172)

  • 1. Inappropriate rise in heart rate caused by intravenous administration of trospium chloride during upper gastrointestinal endoscopy.
    Hasselkus W
    Endoscopy; 1998 Aug; 30(6):580. PubMed ID: 9746172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG; Kadykov AS; Shvedkov VV; Timerbaeva SL; Polevaia EV; Mulach AN
    Urologiia; 2009; (5):24-9. PubMed ID: 20213911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
    Staskin D; Sand P; Zinner N; Dmochowski R;
    J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate increase after intravenous administration of trospium chloride and scopolamine during endoscopic retrograde cholangiopancreatography.
    Pfeiffer A; Kaess H; Bödeker RH; Schwantes U
    Endoscopy; 1999 Aug; 31(6):507. PubMed ID: 10494695
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder.
    MacDiarmid SA; Ellsworth PI; Ginsberg DA; Oefelein MG; Sussman DO
    Urology; 2011 Jan; 77(1):24-9. PubMed ID: 20970833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
    Madersbacher H; Stöhrer M; Richter R; Giannetti BM; Mürtz G
    Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
    Fröhlich G; Bulitta M; Strösser W
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerance of trospium chloride in the high dose range.
    Breuel HP; Mürtz G; Bondy S; Horkulak J; Gianetti BM
    Arzneimittelforschung; 1993 Apr; 43(4):461-4. PubMed ID: 8494577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatment.
    Rudy D; Cline K; Harris R; Goldberg K; Dmochowski R
    BJU Int; 2006 Mar; 97(3):540-6. PubMed ID: 16469022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of once-daily trospium chloride 60 mg extended release and twice-daily trospium chloride 20 mg in healthy adults.
    Silver N; Sandage B; Sabounjian L; Schwiderski U; Shipley J; Harnett M
    J Clin Pharmacol; 2010 Feb; 50(2):143-50. PubMed ID: 19948948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study.
    Walter P; Grosse J; Bihr AM; Kramer G; Schulz HU; Schwantes U; Stöhrer M
    Neurourol Urodyn; 1999; 18(5):447-53. PubMed ID: 10494116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ponalid in the treatment of non-chemical parkinsonism: a souble-blind study with nine months' follow-up.
    Strang RR
    Med J Aust; 1965 Aug; 2(9):360-1. PubMed ID: 5318245
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy--a comparative study with butyl scopolamine bromide.
    Hashimoto T; Adachi K; Ishimura N; Hirakawa K; Katsube T; Kurotani A; Hattori S; Kinoshita Y
    Aliment Pharmacol Ther; 2002 Jan; 16(1):111-8. PubMed ID: 11856085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
    Staskin DR; Cardozo L
    Int J Clin Pract; 2009 Jun; 63(6):973-6. PubMed ID: 19459997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
    Chancellor MB; Oefelein MG; Vasavada S
    Neurourol Urodyn; 2010 Apr; 29(4):551-4. PubMed ID: 19634167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trospium chloride in combined treatment of females with genital prolapse and overactive urinary bladder].
    Shkol'nikov Me; Mazo EB; Krivoborodov GG; Dobrokhotova IuE; Kaĭfadzhan MM; Fandeeva LV; Nurullin RF; Zhdanova MS
    Urologiia; 2008; (5):16-9. PubMed ID: 19069489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sedation with intravenous midazolam during upper gastrointestinal endoscopy--changes in hemodynamics, oxygen saturation and memory].
    Mizuno J; Matsuki M; Gouda Y; Nishiyama T; Hanaoka K
    Masui; 2003 Sep; 52(9):976-80. PubMed ID: 14531257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.